Related Experiment Video
Updated: Aug 21, 2026
One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
A primer on newborn screening
Kristin Gatrell Bryant1, Kimberly M Horns, Nicola Longo
1Newborn Critical Care Services, Primary Children's Medical Center, Salt Lake City, Utah, USA. pckgatre@ifc.com
Insights
Newborn screening identifies rare metabolic disorders in infants, enabling early treatment to prevent severe outcomes. Healthcare providers play a crucial role in educating parents about this vital public health service.
Area of Science:
- Biochemistry
- Pediatrics
- Public Health
Background:
- Metabolic disorders, though individually rare, collectively affect 1 in 1000 to 3000 infants.
- Delayed diagnosis and treatment of these disorders can lead to irreversible harm.
- Newborn screening is a critical public health intervention for early detection.
Purpose of the Study:
- To summarize key aspects of newborn screening.
- To compare national screening practices.
- To identify considerations for clinical care, parental education, and support.
Main Methods:
- Literature review and synthesis of current national newborn screening practices.
- Analysis of guidelines for clinical care and parental education.
Main Results:
- Newborn screening identifies inborn metabolic disorders, hemoglobinopathies, infectious diseases, and congenital endocrinopathies.
- Early recognition and prompt treatment are essential to prevent morbidity and mortality.
- Understanding screening guidelines and implications is crucial for healthcare providers and parents.
Conclusions:
- Newborn screening is vital for early detection and management of serious infant conditions.
- Healthcare providers must be knowledgeable about screening protocols and parental communication.
- Effective parental education and support are integral to successful newborn screening programs.
Abstract:
Metabolic disorders are individually rare, but when considered together as a disease entity are relatively frequent, occurring in 1 in 1000 to 1 in 3000 infants. Some disorders can have devastating and irreversible outcomes if not diagnosed early and treated promptly. Newborn screening is a vital step in identifying infants with inborn metabolic disorders, hemoglobinopathies, infectious processes, and congenital endocrinopathies; the goal is early recognition and treatment. This article summarizes the critical aspects of newborn screening, comparing and contrasting current national screening practices, and identifying key considerations for clinical care, parental education, and support. To prevent morbidity and mortality, healthcare providers must understand the purpose and guidelines for newborn screening. Providers are also responsible for informing parents about the implications of newborn screening to improve awareness and understanding.
